Spotlight Archive
Monday, June 24, 2024
May 2024
Paul Burchard, MD, PGY3
Research focus: My research focused on targeting the highly treatment-resistant tumor microenvironment of cholangiocarcinoma by utilizing a novel agent that disrupts collagen-crosslinking to alter the tumor matrix. Through this project, we were able to reduce tumor stiffness and augment chemotherapeutic penetration to improve tumor control and survival in mouse models of cholangiocarcinoma.
Read more: Paul Burchard, MD